DocDollars

Immunocore Limited

Great Britain (UK) · Reporting entity ID 100001176930

Total reported 2019–2025
$12.8M
#425 of 2,960 reporting companies — 0% of all reported industry payments
$4.64M in general payments across 3,692 records, plus $8.17M in research funding across 1,788 records.

How it breaks down

General payments $4,641,319
Research funding $8,167,507

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Immunocore Limited reported $12.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #425 of 2,960 reporting companies. 64% of that was research funding and 36% general payments such as consulting, speaking, food and travel. 3,692 general payment records and 1,788 research records were filed.

Common questions about Immunocore Limited

How much has Immunocore Limited paid US doctors?

Immunocore Limited reported $12,808,826 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,641,319 in general payments, $8,167,507 in research funding.

How does Immunocore Limited rank among drug and device companies?

It ranks #425 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Immunocore Limited mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.